Damn_老虎社区_美港股上老虎

Saltyninjazz
2021-10-11

Damn

Facebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says

Recent revelations and scrutiny from Congress over Facebook’s role in society could lead to major la

Facebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":826084514,"tweetId":"826084514","gmtCreate":1633959302194,"gmtModify":1633960241818,"author":{"id":3576456241160292,"authorId":3576456241160292,"authorIdStr":"3576456241160292","name":"Saltyninjazz","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":10,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Damn</p></body></html>","htmlText":"<html><head></head><body><p>Damn</p></body></html>","text":"Damn","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/826084514","repostId":1108627633,"repostType":4,"repost":{"id":"1108627633","pubTimestamp":1633957828,"share":"https://www.laohu8.com/m/news/1108627633?lang=&edition=full","pubTime":"2021-10-11 21:10","market":"us","language":"en","title":"Facebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1108627633","media":"Barrons","summary":"Recent revelations and scrutiny from Congress over Facebook’s role in society could lead to major la","content":"<p>Recent revelations and scrutiny from Congress over Facebook’s role in society could lead to major lawsuits against the social-media giant, according to new research that drew comparisons with litigation faced by Big Tobacco or Purdue Pharma.</p>\n<p>Facebook has been under pressure following a series of reports by The Wall Street Journal that made allegations covering Instagram’s impact on teenagers’ mental health, whether its algorithm encouraged social discord, and how it moderates elites.</p>\n<p></p>\n<p>A company whistleblower who leaked internal documents to the Journal also testified before Congress last week, as lawmakers turned their attention to the renewed public debate over Facebook’s prominent role in peoples’ lives.</p>\n<p>Facebook co-founder and CEO Mark Zuckerberg last week said that “many of the claims don’t make any sense,” pushing back against allegations that arose in the Journal’s reports and the whistleblower’s testimony, in a post on social media.</p>\n<p>Blair Levin, an analyst at London-based technology industry research group New Street Research, wrote Sunday that “while we have been skeptical that past revelations would lead to government action, we think this time is different and as a result, we think Facebook may now face a similar challenge from increased litigation as tobacco, or more recently, OxyContin.”</p>\n<p>Levin served as chief of staff to the chair of the Federal Communications Commission in the 1990s.</p>\n<p>The analyst said that while the facts and damages are different for Facebook than those faced by the tobacco industry or Purdue Pharma—the maker of opioid medication&nbsp;OxyContin—the fundamental legal framework is the same.</p>\n<p>There is a product with problematic consequences for many people, management knowledge of such, and actions by management “that not only failed to mitigate the harm but arguably increased those problematic consequences,” Levin said.</p>\n<p>In the same way that public outcry against tobacco and opioid makers led to massive class action and state attorneys general-led lawsuits, Levin said the recent revelations against Facebook creates similar incentives to bring litigation against the company.</p>\n<p>While Facebook has faced scrutiny before, there is far more attention on the company this time, in part because of the role that harms to children plays in the recent allegations, Levin noted.</p>\n<p>“Discovery is likely to yield even more problematic evidence for Facebook, and the dynamics create an opportunity for a settlement that would address the issues more quickly than legislation,” Levin said. “We think litigation is likely to be more damaging to Facebook than legislation.”</p>\n<p>Facebook&nbsp;(ticker: FB) stock was 0.7% lower in U.S. premarket trade Monday. The stock is down 12.3% over the past month.</p>\n<p>Facebook didn’t immediately respond to a request for comment.</p>\n<p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Facebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFacebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/facebook-faces-legal-risk-big-tobacco-oxycontin-51633956119?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recent revelations and scrutiny from Congress over Facebook’s role in society could lead to major lawsuits against the social-media giant, according to new research that drew comparisons with ...</p>\n\n<a href=\"https://www.barrons.com/articles/facebook-faces-legal-risk-big-tobacco-oxycontin-51633956119?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/facebook-faces-legal-risk-big-tobacco-oxycontin-51633956119?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108627633","content_text":"Recent revelations and scrutiny from Congress over Facebook’s role in society could lead to major lawsuits against the social-media giant, according to new research that drew comparisons with litigation faced by Big Tobacco or Purdue Pharma.\nFacebook has been under pressure following a series of reports by The Wall Street Journal that made allegations covering Instagram’s impact on teenagers’ mental health, whether its algorithm encouraged social discord, and how it moderates elites.\n\nA company whistleblower who leaked internal documents to the Journal also testified before Congress last week, as lawmakers turned their attention to the renewed public debate over Facebook’s prominent role in peoples’ lives.\nFacebook co-founder and CEO Mark Zuckerberg last week said that “many of the claims don’t make any sense,” pushing back against allegations that arose in the Journal’s reports and the whistleblower’s testimony, in a post on social media.\nBlair Levin, an analyst at London-based technology industry research group New Street Research, wrote Sunday that “while we have been skeptical that past revelations would lead to government action, we think this time is different and as a result, we think Facebook may now face a similar challenge from increased litigation as tobacco, or more recently, OxyContin.”\nLevin served as chief of staff to the chair of the Federal Communications Commission in the 1990s.\nThe analyst said that while the facts and damages are different for Facebook than those faced by the tobacco industry or Purdue Pharma—the maker of opioid medication OxyContin—the fundamental legal framework is the same.\nThere is a product with problematic consequences for many people, management knowledge of such, and actions by management “that not only failed to mitigate the harm but arguably increased those problematic consequences,” Levin said.\nIn the same way that public outcry against tobacco and opioid makers led to massive class action and state attorneys general-led lawsuits, Levin said the recent revelations against Facebook creates similar incentives to bring litigation against the company.\nWhile Facebook has faced scrutiny before, there is far more attention on the company this time, in part because of the role that harms to children plays in the recent allegations, Levin noted.\n“Discovery is likely to yield even more problematic evidence for Facebook, and the dynamics create an opportunity for a settlement that would address the issues more quickly than legislation,” Levin said. “We think litigation is likely to be more damaging to Facebook than legislation.”\nFacebook (ticker: FB) stock was 0.7% lower in U.S. premarket trade Monday. The stock is down 12.3% over the past month.\nFacebook didn’t immediately respond to a request for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":458,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Facebook Faces Legal Risk Similar to Big Tobacco or OxyContin, Analyst Says

评论（1）

热议股票